Rivastigmine Twice Weekly Transdermal Patch (Luye Pharma)

利斯的明透皮贴剂 (绿叶制药)

Report date: 2025/11/28 20:00:57

Base Information

Drug NameRivastigmine Twice Weekly Transdermal Patch (Luye Pharma)
Drug Alias NameRivastigmine MD利斯的明多日透皮贴剂Rivastigmine transdermal (Luye Pharma)利斯的明多天贴剂Rivastigmine Twice Weekly Transdermal Patch +[16] 
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsButyrylcholinesterase inhibitors
TargetsAcetylcholinesteraseButyrylcholinesterase
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsAlzheimer Disease
Approved Indications in ChinaAlzheimer Disease
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryGermanyEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAcino International AG
China Registration ClassN/A

Develop Information

Active CompaniesLuye Pharma Group LtdItalfarmaco SpaTowa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A